BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28693015)

  • 21. Knowledge, attitudes, and practice of the Pap smear test in female college students attending a global university in the United States.
    Tolosko JA; Beauchesne M; Rancatore E
    J Am Assoc Nurse Pract; 2023 May; 35(5):322-329. PubMed ID: 36862575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid based cytology: a new cervical screening system for the UK.
    Wall A
    J Fam Health Care; 2005; 15(3):90-2. PubMed ID: 16094904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical Cancer Screening: Recommendations for Muslim Societies.
    Khodakarami N; Farzaneh F; Yavari P; Akbari ME
    Asian Pac J Cancer Prev; 2016; 17(1):239-47. PubMed ID: 26838217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cancer screening for survivors diagnosed with cancer before age 25.
    Tseng OL; Spinelli JJ; Dawes M; McBride ML
    J Cancer Surviv; 2017 Jun; 11(3):410-419. PubMed ID: 28127670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematoidin crystals in Pap smear: A revisit.
    Thakur A; Sarin H
    Diagn Cytopathol; 2020 Jan; 48(1):92. PubMed ID: 31714034
    [No Abstract]   [Full Text] [Related]  

  • 27. The current status of the Papanicolaou smear.
    Shingleton HM; Patrick RL; Johnston WW; Smith RA
    CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides.
    Tsiambas E; Riziotis C
    Pathol Int; 2017 Jan; 67(1):24-31. PubMed ID: 27891686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a worksite cervical screening initiative to increase Pap smear uptake in Malaysia: a cluster randomized controlled trial.
    Abdullah F; O'Rorke M; Murray L; Su TT
    Biomed Res Int; 2013; 2013():572126. PubMed ID: 24073411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "A Pap smear saved my life": Personal experiences of cervical abnormalities shape attitudes to cervical screening renewal.
    Obermair HM; McCaffery KJ; Dodd RH
    J Med Screen; 2020 Dec; 27(4):223-226. PubMed ID: 31771406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical cancer screening: the complex interplay of medical infrastructure, society, and culture.
    Goodman A; Nour N
    Oncologist; 2014 Apr; 19(4):315-7. PubMed ID: 24682462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV for cervical cancer screening: is the era of the molecular pap smear upon us?
    Stoler MH
    J Histochem Cytochem; 2001 Sep; 49(9):1197-8. PubMed ID: 11511693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical cancer screening: How our approach may change.
    Hofmeister S
    J Fam Pract; 2016 Aug; 65(8):551-3. PubMed ID: 27660838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring Effective Contextual Factors for Regular Cervical Cancer Screening in Iranian Women: A Qualitative Study.
    Refaei M; Dehghan Nayeri N; Khakbazan Z; Yazdkhasti M; Shayan A
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):533-539. PubMed ID: 29480997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
    Rahangdale L; Sarnquist C; Yavari A; Blumenthal P; Israelski D
    J Womens Health (Larchmt); 2010 Apr; 19(4):709-12. PubMed ID: 20201703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
    Linder J; Zahniser D
    Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolution of the Papanicolaou smear.
    Tambouret RH
    Clin Obstet Gynecol; 2013 Mar; 56(1):3-9. PubMed ID: 23314726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
    Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
    Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
    Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.